Neuberger Berman Group LLC boosted its position in shares of Danaher Corporation (NYSE:DHR) by 1.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,191,861 shares of the conglomerate’s stock after purchasing an additional 39,276 shares during the quarter. Neuberger Berman Group LLC owned about 0.46% of Danaher worth $273,798,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently made changes to their positions in the business. National Asset Management Inc. raised its holdings in Danaher by 0.4% during the 2nd quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock worth $318,000 after purchasing an additional 14 shares during the last quarter. First Financial Corp IN grew its position in shares of Danaher by 0.8% during the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock worth $230,000 after buying an additional 21 shares during the period. Brighton Jones LLC grew its position in shares of Danaher by 0.4% during the 2nd quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock worth $435,000 after buying an additional 21 shares during the period. Buckingham Asset Management LLC grew its position in shares of Danaher by 0.4% during the 2nd quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock worth $488,000 after buying an additional 24 shares during the period. Finally, Simmons Bank grew its position in shares of Danaher by 0.4% during the 2nd quarter. Simmons Bank now owns 7,160 shares of the conglomerate’s stock worth $604,000 after buying an additional 26 shares during the period. 76.32% of the stock is owned by hedge funds and other institutional investors.
In related news, CFO Daniel L. Comas sold 88,184 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of $91.02, for a total value of $8,026,507.68. Following the completion of the transaction, the chief financial officer now directly owns 227,816 shares in the company, valued at approximately $20,735,812.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Robert S. Lutz sold 11,189 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $91.66, for a total value of $1,025,583.74. Following the completion of the transaction, the chief accounting officer now owns 18,314 shares of the company’s stock, valued at $1,678,661.24. The disclosure for this sale can be found here. Insiders sold a total of 273,810 shares of company stock valued at $25,218,813 over the last quarter. 12.20% of the stock is owned by insiders.
Danaher Corporation (NYSE:DHR) opened at $93.21 on Tuesday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a 12-month low of $77.52 and a 12-month high of $94.82. The stock has a market capitalization of $64,816.49, a P/E ratio of 23.95, a P/E/G ratio of 2.22 and a beta of 1.02.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The business had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. During the same period in the previous year, the firm earned $0.87 EPS. Danaher’s quarterly revenue was up 9.6% compared to the same quarter last year. research analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a $0.14 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. Danaher’s dividend payout ratio is presently 16.52%.
Several research firms have recently issued reports on DHR. Robert W. Baird boosted their target price on Danaher from $87.00 to $97.00 and gave the stock an “outperform” rating in a research report on Friday, October 20th. Credit Suisse Group boosted their target price on Danaher from $93.00 to $96.00 and gave the stock an “outperform” rating in a research report on Friday, October 20th. Morgan Stanley boosted their target price on Danaher from $95.00 to $98.00 and gave the stock an “overweight” rating in a research report on Friday, October 20th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a research report on Thursday, October 5th. Finally, J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 target price on shares of Danaher in a research report on Friday, September 8th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $93.31.
COPYRIGHT VIOLATION NOTICE: “Neuberger Berman Group LLC Purchases 39,276 Shares of Danaher Corporation (DHR)” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/12/neuberger-berman-group-llc-purchases-39276-shares-of-danaher-corporation-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.